当前位置:首页 - 行情中心 - 药石科技(300725) - 财务分析 - 现金流量表

药石科技

(300725)

  

流通市值:77.01亿  总市值:88.82亿
流通股本:2.03亿   总股本:2.34亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,545,415,387.341,163,025,106.38647,144,030.741,745,674,969.12
  收到的税费返还39,125,824.5833,005,462.1720,390,537.4549,771,189.98
  收到其他与经营活动有关的现金21,584,658.520,274,232.2112,784,267.723,676,208.01
  经营活动现金流入小计1,606,125,870.421,216,304,800.76680,318,835.891,819,122,367.11
  购买商品、接受劳务支付的现金461,685,552.17332,193,194.98200,191,598.39746,997,798.22
  支付给职工以及为职工支付的现金479,635,079.19332,567,330.71186,430,721.48591,690,020.08
  支付的各项税费70,952,074.8954,408,297.6820,248,054.69100,625,692.72
  支付其他与经营活动有关的现金50,370,559.4630,223,025.4921,106,913.2576,985,851.55
  经营活动现金流出小计1,062,643,265.71749,391,848.86427,977,287.811,516,299,362.57
  经营活动产生的现金流量净额543,482,604.71466,912,951.9252,341,548.08302,823,004.54
二、投资活动产生的现金流量:
  收回投资收到的现金2,219,896,932.131,187,030,887.08525,916,843.983,892,165,776.57
  取得投资收益收到的现金13,930,353.787,139,278.894,661,672.1546,612,191.84
  处置固定资产、无形资产和其他长期资产收回的现金净额183,565.747,964.6-10,305
  投资活动现金流入小计2,234,010,851.651,194,178,130.57530,578,516.133,938,788,273.41
  购建固定资产、无形资产和其他长期资产支付的现金58,136,575.4662,381,555.0525,628,619.36118,124,149.78
  投资支付的现金2,483,581,394.511,441,924,903.89354,789,580.293,885,627,624.83
  支付其他与投资活动有关的现金---11,142,100
  投资活动现金流出小计2,541,717,969.971,504,306,458.94380,418,199.654,014,893,874.61
  投资活动产生的现金流量净额-307,707,118.32-310,128,328.37150,160,316.48-76,105,601.2
三、筹资活动产生的现金流量:
  取得借款收到的现金100,000,000--250,007,357.22
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计100,000,000--250,007,357.22
  偿还债务支付的现金275,007,357.2245,007,357.2245,007,357.22628,413,500
  分配股利、利润或偿付利息支付的现金69,489,134.3468,767,939.16825,932.2877,972,130.76
  支付其他与筹资活动有关的现金2,675,327.73885,730.15713,211.6112,581,688.95
  筹资活动现金流出小计347,171,819.29114,661,026.5346,546,501.11718,967,319.71
  筹资活动产生的现金流量净额-247,171,819.29-114,661,026.53-46,546,501.11-468,959,962.49
四、汇率变动对现金及现金等价物的影响1,465,968.39-10,892-672,170.3324,171,474.45
五、现金及现金等价物净增加额-9,930,364.5142,112,705355,283,193.12-218,071,084.7
  加:期初现金及现金等价物余额290,200,624.44290,200,624.44290,200,624.44508,271,709.14
  期末现金及现金等价物余额280,270,259.93332,313,329.44645,483,817.56290,200,624.44
补充资料:
  净利润-72,498,099.12-219,539,833.88
  资产减值准备-24,971,667.39-65,803,380.99
  固定资产和投资性房地产折旧-62,559,004.34-125,156,232.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-62,559,004.34-125,156,232.94
  无形资产摊销-3,059,806.06-5,626,939.69
  长期待摊费用摊销-2,126,281.52-5,935,443.75
  固定资产报废损失-1,045,646.01-962,870.05
  公允价值变动损失-434,704.1--9,360,884.19
  财务费用-26,680,460.55-37,259,346.81
  投资损失--11,059,877.09--35,436,886.52
  递延所得税--4,751,804.91-3,799,084.42
  其中:递延所得税资产减少--3,186,223.91-5,979,772.28
    递延所得税负债增加--1,565,581--2,180,687.86
  存货的减少-81,440,589.01--175,244,393.02
  经营性应收项目的减少-158,855,636.96--60,108,183.5
  经营性应付项目的增加-45,681,687.75-116,811,593.69
  其他-1,641,649.1--353,401.85
  现金的期末余额-332,313,329.44-290,200,624.44
  减:现金的期初余额-290,200,624.44-508,271,709.14
  现金及现金等价物的净增加额-42,112,705--218,071,084.7
公告日期2025-10-302025-08-082025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑